Upperton Pharma Solutions, a renowned UK-based contract development and manufacturing organisation (CDMO), has finalised the construction of its cutting-edge sterile manufacturing facility in Nottingham, UK. The £7 million facility adds to the company’s existing 50,000 sq. ft Trent Gateway site and has been purpose-built to meet the updated requirements of the EU GMP Annex-1 guidelines. Spanning 7…
